Product image of Evra (Ethinylestradiol, Norelgestromin) supplied by GNH India

Evra

Active Ingredient:
Ethinylestradiol, Norelgestromin
Origin:
EU

Evra (Ethinylestradiol, Norelgestromin)

Evra is a transdermal contraceptive patch containing Ethinylestradiol and Norelgestromin. It is designed to prevent pregnancy by releasing hormones through the skin. This patch is a convenient option for those seeking hormonal birth control.

Manufacturer / TM Owner

Gedeon Richter Plc.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Evra is primarily used for birth control. The patch works by releasing hormones that prevent ovulation, thicken cervical mucus, and thin the uterine lining. This combination makes it difficult for sperm to reach an egg and for a fertilized egg to implant in the uterus. Many people use Evra as a reliable method of contraception.

Side Effects

  • Common effects of using Evra may include skin irritation at the application site, breast tenderness, headaches, and nausea. Some users may also experience changes in menstrual bleeding patterns. These effects vary among individuals and typically subside as the body adjusts to the hormones.

Precautions & Warnings

  • Evra should be used with caution in individuals with a history of blood clots, high blood pressure, or certain types of cancer. It is important to follow the instructions provided by a healthcare professional regarding the application and replacement of the patch. Regular monitoring may be necessary to ensure safety and effectiveness.

Avoid Interactions

  • Evra may interact with certain medications, including those that affect liver enzymes, such as some antibiotics and anticonvulsants. It is advisable to consult a healthcare professional before starting Evra if you are taking other medications. Additionally, smoking can increase the risk of serious side effects.

Frequently Asked Questions

Evra is used primarily for birth control. It works by releasing hormones through the skin to prevent pregnancy.

The Evra patch is typically changed once a week for three weeks, followed by a one-week patch-free interval.

Yes, skin irritation at the application site is a common effect of using Evra.

Evra may not be suitable for individuals with certain medical conditions, such as a history of blood clots or high blood pressure.

It is important to consult a healthcare professional before using Evra if you are taking other medications, as they may interact with the patch.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ethinylestradiol, Norelgestromin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT